Filing metadata

Accession number
0001209191-22-011841
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Feb 22, 2022
Reporting period
Feb 18, 2022
Description
Insider transaction

Explore SEC Filings Hub